(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Wednesday that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration ...
It may seem like just yesterday, OK it was around 1997, when an HPV (human papillomavirus) test was approved for use by the FDA with a specific media— ThinPrep—as an important triage test for women ...
Becton, Dickinson or BD (BDX +2.0%) has submitted a pre-market approval (PMA) supplement to FDA for the use of the ThinPrep Pap Test PreservCyt Solution vial as an approved sample type for its ...
Roche has announced that it has received U.S. Food and Drug Administration (FDA) approval for performing the cobas® HPV Test from cervical specimens collected in BD SurePath™ Preservative Fluid using ...
FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...
Roche cobas HPV Test gained U.S. Food and Drug Administration (FDA) approval for the use with SurePath Preservative Fluid to detect human papilloma virus (HPV) in cervical cells. SurePath is one of ...
We compared the sensitivity and specificity of liquid-based cytology (LBC) and computer-assisted reading for SurePath/FocalPoint and ThinPrep with those of manually read conventional cytology in ...
FRANKLIN LAKES, N.J. , Sept. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market ...
FRANKLIN LAKES, N.J., Sept. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results